Breaking News Instant updates and real-time market news.

GOOG

Alphabet

$920.29

-4.82 (-0.52%)

, GOOGL

Alphabet Class A

$935.29

-4.84 (-0.51%)

18:12
09/17/17
09/17
18:12
09/17/17
18:12

Alphabet Waymo seeking delay in self-driving trade secret trial, Reuters says

Alphabet's Waymo self-driving car unit said given the critical new evidence recently obtained in a trade secret lawsuit against Uber, a U.S. judge should postpone a trial of the case set to begin next month, according to Reuters. Waymo claimed in a lawsuit that former engineer Anthony Levandowski downloaded more than 14,000 confidential files before leaving to set up a self-driving truck company, which Uber acquired soon after, the publication noted.Reference Link

GOOG

Alphabet

$920.29

-4.82 (-0.52%)

GOOGL

Alphabet Class A

$935.29

-4.84 (-0.51%)

  • 29

    Nov

GOOG Alphabet
$920.29

-4.82 (-0.52%)

09/08/17
UBSW
09/08/17
NO CHANGE
Target $1080
UBSW
Buy
Deal for HTC handsets would be immaterial to Alphabet financials, says UBS
UBS analyst Eric Sheridan commented on the media report Alphabet is in the final stages of negotiating the purchase of the smartphone business of HTC. The analyst feels the financial implications are immaterial to Alphabet but admitted it opens the debate about the strategic plan of the acquisition. He feels owning and operating its own mobile division would offset some of the key challenges that Google's mobile computing business might face. Sheridan reiterated his Buy rating and $1,080 price on Alphabet shares.
09/11/17
BARD
09/11/17
NO CHANGE
Target $1100
BARD
Outperform
Alphabet well positioned to expand AR platform, says Baird
Baird analyst Colin Sebastian believes Alphabet is well positioned to expand its Augmented Reality, or AR, platform, which could lead to a justification of a tie-up with HTC's mobile/R&D assets. The analyst believe Alphabet is in a position to expand and stimulate growth of AR applications and an acquisition of the HTC mobile business will help with that along with protecting its Pixel production supply chain. Sebastian reiterated his Outperform rating and $1,100 price target on Alphabet shares.
09/12/17
MSCO
09/12/17
NO CHANGE
MSCO
Augmented Reality the next 'killer app' to power Apple, says Morgan Stanley
A team of Morgan Stanley analysts including Katy Huberty, Brian Nowak and Grace Chen, among others, state in a new note to investors that they view Augmented Reality, or AR, as a revolutionary trend that can be "the next killer app" to extend the life of the smartphone market and accelerate device upgrades, led by Apple's (AAPL) iPhone. The analysts, who compare the impact of AR to the launch of Apple's App Store nearly a decade ago, add that they "don't expect the Android ecosystem to stand still in response." Huberty and the team raised the firm's "bull case" valuation of Apple, which they see taking the lead in AR, to $253 from $203. While they see Apple as "the clear leader" in AR, Google (GOOG) and Tencent (TCEHY) are also well-positioned and "interesting use cases" in e-commerce could benefit Alibaba (BABA) and Amazon (AMZN), they add.
09/14/17
BARD
09/14/17
NO CHANGE
Target $1100
BARD
Outperform
Alphabet TAC cost may moderate in coming quarters, says Baird
Baird analyst Colin Sebastian said his analysis suggests traffic acquisition cost, or TAC, headwinds for Google may moderate in coming quarters. He believes Alphabet shares have been range bound due to TAC-related margin pressures, but they could moderate earlier than many investors anticipate, in part due to the company lapping distribution agreements. Sebastian reiterated his Outperform rating and $1,100 price target on Alphabet shares.
GOOGL Alphabet Class A
$935.29

-4.84 (-0.51%)

08/30/17
AGIS
08/30/17
NO CHANGE
AGIS
Aegis sees signs of start of advertising recession
After speaking with Bryan Wiener, the Executive Chairman of online and traditional advertising agency 360i, Aegis analyst Victor Anthony said that his commentary, along with earnings results from ad agencies Interpublic Group (IPG) and WPP (WPPGY), leave him of the opinion that an ad recession is underway. Wiener believes Google (GOOG), Facebook (FB) and Amazon (AMZN) will be relatively insulated given they will continue to take share, and Anthony said he would continue to buy Alphabet and Facebook shares. The analyst keeps a Hold rating on Snap (SNAP) and a Sell rating on Twitter (TWTR).
09/05/17
WELS
09/05/17
NO CHANGE
WELS
Google remediation plan could help frame risk in shopping, says Wells Fargo
Wells Fargo notes that Google has submitted a plan to comply with the EU's shopping search decision ahead of a September 28 deadline. While Google's revenue exposure here is likely modest, it could face EU regulatory scrutiny in additional verticals, the firm added. Wells Fargo believes EU requirements for ''equal treatment'' of competitors remain vague, and Google's remediation plan could help frame the risk in shopping and other verticals.
09/11/17
RBCM
09/11/17
NO CHANGE
RBCM
Alphabet TAC expense could rise due to EU regulatory action, says RBC Capital
RBC Capital analyst Mark S.F. Mahaney says that the EU could force Google to unbundle Android from its other services, which in turn would increase Alphabet's traffic acquisition costs, or TAC. The analyst says that Alphabet faces the greatest regulatory risk among the large cap Internet stocks. However, he keeps an Outperform rating on the shares, citing what he sees as " sustainable & scarce premium growth, significant option value & reasonable valuation."

TODAY'S FREE FLY STORIES

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/26/18
09/26
10:16
09/26/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$151.89

2.98 (2.00%)

10:15
09/26/18
09/26
10:15
09/26/18
10:15
Hot Stocks
IBM rises after UBS says buy on AI potential, low public cloud exposure »

In a research note to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

10:15
09/26/18
09/26
10:15
09/26/18
10:15
General news
Breaking General news story  »

Week of 9/21 EIA…

SVMK

SurveyMonkey

$0.00

(0.00%)

10:13
09/26/18
09/26
10:13
09/26/18
10:13
Syndicate
SurveyMonkey indicated to open at $20, IPO priced at $12 »

SurveyMonkey (SVMK)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BBVA

Banco Bilbao

$6.55

-0.035 (-0.53%)

10:12
09/26/18
09/26
10:12
09/26/18
10:12
Hot Stocks
Banco Bilbao designates CEO Carlos Torres Vila as next chairman »

The board BBVA approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

F

Ford

$9.37

-0.025 (-0.27%)

, VLKAY

Volkswagen

$0.00

(0.00%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Periodicals
Ford expands partnership talks with VW, Mahindra to cut costs, Reuters reports »

Ford (F) CEO Jim Hackett…

F

Ford

$9.37

-0.025 (-0.27%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

SQ

Square

$94.76

-0.64 (-0.67%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Options
Heavy trading in Square weekly options as shares fall from record highs »

Heavy trading in Square…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 26

    Nov

ETTX

Entasis Therapeutics

$0.00

(0.00%)

10:03
09/26/18
09/26
10:03
09/26/18
10:03
Syndicate
Entasis Therapeutics opens at $13.45, IPO priced at $15.00 per share »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WOR

Worthington

$42.88

-3.39 (-7.33%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Worthington falls -7.4% »

Worthington is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Options
Active trading in GoPro weekly options as shares spike »

Active trading in GoPro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATU

Actuant

$27.10

-2.65 (-8.91%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Actuant falls -7.9% »

Actuant is down -7.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PES

Pioneer Energy

$3.13

-0.325 (-9.42%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Pioneer Energy falls -8.1% »

Pioneer Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BFR

BBVA Banco Frances

$12.83

0.63 (5.16%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
BBVA Banco Frances rises 5.4% »

BBVA Banco Frances is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRS

Irsa Inversiones y Representaciones SA

$18.00

1.18 (7.02%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Irsa Inversiones y Representaciones SA rises 7.3% »

Irsa Inversiones y…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBD

Care Concepts I, Inc.

$24.22

(0.00%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Care Concepts I, Inc. rises 6.6% »

Care Concepts I, Inc. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
GoPro rises following analyst upgrade on 'compelling' products »

Shares of GoPro (GPRO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

, AMC

AMC Entertainment

$20.05

0.175 (0.88%)

09:56
09/26/18
09/26
09:56
09/26/18
09:56
Hot Stocks
Helios and Matheson sinks as AMC's Stubs A-List surpasses 380,000 members »

Shares of MoviePass…

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

AMC

AMC Entertainment

$20.05

0.175 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

SCG

Scana

$36.25

0.96 (2.72%)

, ALXN

Alexion

$134.40

5.4 (4.19%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Options
Early notable gainers among liquid option names on September 26th »

Notable gainers among…

SCG

Scana

$36.25

0.96 (2.72%)

ALXN

Alexion

$134.40

5.4 (4.19%)

VIAB

Viacom

$33.80

1.32 (4.06%)

NLSN

Nielsen

$28.00

0.795 (2.92%)

GE

General Electric

$11.42

0.15 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 18

    Feb

ABBV

AbbVie

$94.50

0.72 (0.77%)

, VRTX

Vertex

$184.11

1.54 (0.84%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Xu,…

ABBV

AbbVie

$94.50

0.72 (0.77%)

VRTX

Vertex

$184.11

1.54 (0.84%)

ACER

Acer Therapeutics

$30.55

(0.00%)

BHVN

Biohaven Pharmaceutical

$37.47

(0.00%)

CELG

Celgene

$88.38

0.82 (0.94%)

EXEL

Exelixis

$17.38

0.19 (1.11%)

PTLA

Portola Pharmaceuticals

$28.27

0.57 (2.06%)

BMY

Bristol-Myers

$62.20

0.38 (0.61%)

BIIB

Biogen

$342.79

1.21 (0.35%)

AMGN

Amgen

$208.06

1.59 (0.77%)

BLUE

Bluebird Bio

$141.90

(0.00%)

ONCE

Spark Therapeutics

$57.63

0.07 (0.12%)

LOXO

Loxo Oncology

$164.55

-2.25 (-1.35%)

RCKT

Rocket Pharmaceuticals

$25.11

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 01

    Dec

  • 31

    Dec

  • 14

    Jan

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

KO

Coca-Cola

$45.79

0.105 (0.23%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Environment and Public Works Committee to hold a hearing »

The Committee holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 30

    Oct

TWTR

Twitter

$28.85

-0.26 (-0.89%)

, T

AT&T

$33.80

0.04 (0.12%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Commerce, Science & Transportation Committee to hold a hearing »

The Committee holds a…

TWTR

Twitter

$28.85

-0.26 (-0.89%)

T

AT&T

$33.80

0.04 (0.12%)

GOOG

Alphabet

$1,180.39

-4.17 (-0.35%)

CHTR

Charter

$325.69

2.3 (0.71%)

AMZN

Amazon.com

$1,964.97

-9.53 (-0.48%)

AAPL

Apple

$221.94

-0.25 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 04

    Oct

  • 21

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 28

    Oct

  • 06

    Nov

  • 07

    Nov

  • 12

    Nov

  • 03

    Mar

AVHI

A.V. Homes

$21.48

(0.00%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
A.V. Homes to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 15

    Nov

PFE

Pfizer

$44.07

0.27 (0.62%)

, AMGN

Amgen

$208.06

1.59 (0.77%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Drug Information Association to hold a virtual conference »

Biosimilar Reimbursement…

PFE

Pfizer

$44.07

0.27 (0.62%)

AMGN

Amgen

$208.06

1.59 (0.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 10

    Oct

  • 17

    Oct

  • 22

    Oct

  • 30

    Oct

  • 09

    Nov

PTE

PolarityTE

$20.11

-1 (-4.74%)

, COOL

Ticker changed to PTE

$0.00

(0.00%)

09:53
09/26/18
09/26
09:53
09/26/18
09:53
Periodicals
Violations found by FDA at PolarityTE facility, Capitol Forum says »

The FDA send a Form 483…

PTE

PolarityTE

$20.11

-1 (-4.74%)

COOL

Ticker changed to PTE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.